Morgan Stanley Sees Growth Acceleration As Key To Thesis For Abbott Laboratories
June 30, 2014 at 08:52 AM EDT
In a report published Monday, Morgan Stanley analyst David R. Lewis reiterated an Overweight rating and $45.00 price target on Abbott ...